Updated 3 November 2026 · Root & Evidence editorial content · No independent clinical review claimed
Newly added studies, review updates, and safety context, with a clear record of what changed on Root & Evidence.
Last editorial update: 3 November 2026. These are updates to our coverage, not claims that the papers were just published. Source publication years and site-update dates are shown separately. This section is manually curated; it is not an automated news feed or continuous safety-alert service.
4 updates
Source publication: 2025
The guide previously focused on a small diabetes trial. It now includes the 2025 meta-analysis of nine randomized trials and 649 participants, including null pooled findings and the fragile blood-pressure signal.
The researchers’ very-low GRADE certainty is attributed to them. This addition does not create a Root & Evidence rating.
Source publication: 2018–2020
The guide previously centered on VITAL. We added REDUCE-IT and STRENGTH to compare populations, formulations, results, and harms in one place.
The interpretation now makes the difference between prescription EPA and other omega-3 preparations more visible. These trials are not direct head-to-head comparisons.
Source publication: 2025
The bisglycinate trial now has a structured snapshot, studied dose, participant count, and limitations alongside the guide.
The reported effect is small and based on self-reported symptoms; this does not establish a preferred magnesium form or a personal insomnia dose.
Source publication: Ongoing official safety guidance
The guide now explicitly highlights reported liver injury and pregnancy, thyroid, autoimmune, and medication considerations, with a link to NCCIH.
This is added safety context, not a newly issued alert or a new estimate of risk. It does not establish that every product or user faces the same risk.
Corrections policy ↗ · Suggest a study or report a concern ↗